Enanta is in a strong position to dominate the largely untapped RSV therapeutics market with a Phase III trial on the horizon ...

Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.

A landmark global trial shows that one dose of the RSVPreF3 OA vaccine protects older adults against serious RSV lung disease for three seasons, raising hopes for long-term protection with just a ...

Medical professionals have pleaded for a lifesaving RSV vaccine subsidy, with some high-risk Queenslanders opting to skip the ...

Merck & Co (MSD) has received the European Commission (EC) approval for Enflonsia (clesrovimab), indicated to prevent ...

Children under 2 years of age are at highest risk for getting critically ill from the flu or RSV and requiring intensive care. Currently, doctors can only provide breathing support for severe flu or ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests. Researchers found the respiratory syncytial virus (RSV) ...

CLEVELAND — Health experts are offering guidance on several timely health topics as the season changes, from respiratory illness prevention to safe yard work practices. Akron Children's Hospital is ...

The CDC reports a significant increase in emergency room visits due to RSV in Georgia, with levels higher than the flu and COVID-19. Dr. Ngozika Orjioke notes a rise in RSV cases at her practice, ...